PE35498A1 - Formulacion farmaceutica de famciclovir - Google Patents
Formulacion farmaceutica de famciclovirInfo
- Publication number
- PE35498A1 PE35498A1 PE1997000022A PE00002297A PE35498A1 PE 35498 A1 PE35498 A1 PE 35498A1 PE 1997000022 A PE1997000022 A PE 1997000022A PE 00002297 A PE00002297 A PE 00002297A PE 35498 A1 PE35498 A1 PE 35498A1
- Authority
- PE
- Peru
- Prior art keywords
- famciclovir
- pharmaceutical formulation
- hydroxipropil
- granulate
- cellulose
- Prior art date
Links
- 229960004396 famciclovir Drugs 0.000 abstract 3
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 abstract 3
- 239000001913 cellulose Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229960001179 penciclovir Drugs 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION EN PORCENTAJE EN PESO, QUE COMPRENDE: a) MAS DE 85% (PREFERIBLEMENTE 91,42%) DE FAMCICLOVIR, b) 2,83% DE HIDROXIPROPIL CELULOSA, c) 5% DE ALMIDON GLICOLATO SODICO, d) 0,75% DE ESTEARATO DE MAGNESIO, Y OPCIONALMENTE, e) HASTA 15% DE LACTOSA ANHIDRA. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE DICHO COMPRIMIDO, QUE CONSISTE EN GRANULAR EL FAMCICLOVIR CON UN EXCIPIENTE TAL COMO LA HIDROXIPROPIL CELULOSA, DESPUES, MEZCLAR EL GRANULADO CON LOS OTROS EXCIPIENTES Y COMPRIMIR AL TAMANO Y PESO APROPIADOS. EL FAMCICLOVIR ES LA FORMA ORAL DEL PENCICLOVIR, COMPUESTO QUE PRESENTA ACTIVIDAD ANTIVIRAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9600847.9A GB9600847D0 (en) | 1996-01-16 | 1996-01-16 | Pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE35498A1 true PE35498A1 (es) | 1998-08-07 |
Family
ID=10787105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000022A PE35498A1 (es) | 1996-01-16 | 1997-01-15 | Formulacion farmaceutica de famciclovir |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US6765007B1 (es) |
| EP (1) | EP0874632B1 (es) |
| JP (2) | JP4711360B2 (es) |
| KR (1) | KR100338829B1 (es) |
| CN (1) | CN1132582C (es) |
| AP (2) | AP747A (es) |
| AR (1) | AR005456A1 (es) |
| AT (1) | ATE220910T1 (es) |
| AU (1) | AU713090B2 (es) |
| BG (1) | BG63488B1 (es) |
| BR (1) | BR9706982A (es) |
| CY (1) | CY2390B1 (es) |
| CZ (1) | CZ287205B6 (es) |
| DE (1) | DE69714215T2 (es) |
| DK (1) | DK0874632T3 (es) |
| DZ (1) | DZ2159A1 (es) |
| EA (1) | EA001946B1 (es) |
| EG (1) | EG23684A (es) |
| ES (1) | ES2180922T3 (es) |
| GB (1) | GB9600847D0 (es) |
| HU (1) | HU225472B1 (es) |
| IL (1) | IL124913A0 (es) |
| MX (1) | MX9805713A (es) |
| MY (1) | MY127527A (es) |
| NO (1) | NO315689B1 (es) |
| NZ (1) | NZ326769A (es) |
| OA (1) | OA10812A (es) |
| PE (1) | PE35498A1 (es) |
| PL (1) | PL187291B1 (es) |
| PT (1) | PT874632E (es) |
| SK (1) | SK282132B6 (es) |
| TR (1) | TR199800954T2 (es) |
| TW (1) | TW434016B (es) |
| UA (1) | UA63897C2 (es) |
| UY (2) | UY24437A1 (es) |
| WO (1) | WO1997025990A1 (es) |
| ZA (1) | ZA97310B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007037790A2 (en) * | 2005-06-08 | 2007-04-05 | Elan Corporation, Plc | Modified release famciclovir compositions |
| AU2010265866B2 (en) | 2009-06-26 | 2012-07-12 | Taris Biomedical Llc | Solid drug tablets for implantable drug delivery devices |
| JP2015063521A (ja) * | 2013-09-02 | 2015-04-09 | 科研製薬株式会社 | 高い薬物含有率を有する錠剤及びその製造方法 |
| CN104434852B (zh) * | 2013-09-18 | 2018-11-20 | 北京韩美药品有限公司 | 泛昔洛韦直压片及其制备方法 |
| CN112587491B (zh) * | 2021-01-03 | 2022-08-23 | 迪沙药业集团有限公司 | 一种泛昔洛韦片组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3421800C1 (de) * | 1984-06-12 | 1986-04-17 | Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl | Elastische Walze zum Behandeln einer thermoplastischen Folie |
| DE3582399D1 (de) * | 1984-09-20 | 1991-05-08 | Beecham Group Plc | Purin-derivate und ihre pharmazeutische verwendung. |
| UA37214C2 (uk) * | 1991-01-30 | 2001-05-15 | Дзе Веллкам Фаундейшн Лімітед | Таблетки, що диспергуються у воді, та спосіб їх виготовлення |
| WO1992020816A1 (en) | 1991-05-15 | 1992-11-26 | Yale University | Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| GB9303157D0 (en) * | 1993-02-17 | 1993-03-31 | Scotia Holdings Plc | Treatment of a group of related disorders |
| IL111138A (en) | 1993-10-05 | 1997-04-15 | Smithkline Beecham Plc | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia |
| JP3702594B2 (ja) * | 1997-08-07 | 2005-10-05 | 株式会社明電舎 | パラメータ調節方法及び装置 |
-
1996
- 1996-01-16 GB GBGB9600847.9A patent/GB9600847D0/en active Pending
-
1997
- 1997-01-02 AP APAP/P/1997/000911A patent/AP747A/en active
- 1997-01-10 UY UY24437A patent/UY24437A1/es not_active IP Right Cessation
- 1997-01-13 HU HU9901021A patent/HU225472B1/hu unknown
- 1997-01-13 CZ CZ19982254A patent/CZ287205B6/cs not_active IP Right Cessation
- 1997-01-13 DK DK97901539T patent/DK0874632T3/da active
- 1997-01-13 PT PT97901539T patent/PT874632E/pt unknown
- 1997-01-13 CN CN97191703A patent/CN1132582C/zh not_active Expired - Lifetime
- 1997-01-13 KR KR1019980705371A patent/KR100338829B1/ko not_active Expired - Lifetime
- 1997-01-13 UA UA98063199A patent/UA63897C2/uk unknown
- 1997-01-13 BR BR9706982A patent/BR9706982A/pt not_active IP Right Cessation
- 1997-01-13 DE DE69714215T patent/DE69714215T2/de not_active Expired - Lifetime
- 1997-01-13 JP JP52569297A patent/JP4711360B2/ja not_active Expired - Lifetime
- 1997-01-13 WO PCT/EP1997/000195 patent/WO1997025990A1/en not_active Ceased
- 1997-01-13 PL PL97327922A patent/PL187291B1/pl unknown
- 1997-01-13 EA EA199800573A patent/EA001946B1/ru not_active IP Right Cessation
- 1997-01-13 NZ NZ326769A patent/NZ326769A/xx not_active IP Right Cessation
- 1997-01-13 US US09/101,926 patent/US6765007B1/en not_active Expired - Lifetime
- 1997-01-13 EP EP97901539A patent/EP0874632B1/en not_active Expired - Lifetime
- 1997-01-13 AU AU15418/97A patent/AU713090B2/en not_active Expired
- 1997-01-13 SK SK956-98A patent/SK282132B6/sk not_active IP Right Cessation
- 1997-01-13 ES ES97901539T patent/ES2180922T3/es not_active Expired - Lifetime
- 1997-01-13 AP APAP/P/1998/001298A patent/AP1114A/en active
- 1997-01-13 AT AT97901539T patent/ATE220910T1/de active
- 1997-01-13 TR TR1998/00954T patent/TR199800954T2/xx unknown
- 1997-01-13 IL IL12491397A patent/IL124913A0/xx not_active IP Right Cessation
- 1997-01-14 EG EG4697A patent/EG23684A/xx active
- 1997-01-14 TW TW086100335A patent/TW434016B/zh not_active IP Right Cessation
- 1997-01-14 AR ARP970100130A patent/AR005456A1/es active IP Right Grant
- 1997-01-15 ZA ZA9700310A patent/ZA97310B/xx unknown
- 1997-01-15 DZ DZ970004A patent/DZ2159A1/fr active
- 1997-01-15 PE PE1997000022A patent/PE35498A1/es not_active IP Right Cessation
- 1997-01-15 MY MYPI97000137A patent/MY127527A/en unknown
- 1997-05-16 UY UY24556A patent/UY24556A1/es not_active IP Right Cessation
-
1998
- 1998-07-15 MX MX9805713A patent/MX9805713A/es unknown
- 1998-07-15 NO NO19983259A patent/NO315689B1/no not_active IP Right Cessation
- 1998-07-15 BG BG102638A patent/BG63488B1/bg unknown
- 1998-07-16 OA OA9800116A patent/OA10812A/en unknown
-
2003
- 2003-11-28 CY CY0300085A patent/CY2390B1/xx unknown
-
2008
- 2008-11-19 JP JP2008295818A patent/JP2009091362A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ336789A (en) | Use of methacrylic acid copolymer type C in the manufacture of tablets | |
| MX9308188A (es) | Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida. | |
| AP2397A (en) | Matrix for sustained, invariant and independent release of active compounds. | |
| KR890001526A (ko) | 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법 | |
| ES2191034T3 (es) | Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas. | |
| AR054782A2 (es) | Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico | |
| KR840005661A (ko) | 지속성 매트릭스 정제 조성물의 제조방법 | |
| AR037930A1 (es) | Formulaciones de acitromicina directamente compresibles | |
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| ES2063033T3 (es) | Empleo de igf-ii en el tratamiento de la enfermedades de los huesos. | |
| ES2084174T3 (es) | Productos y procesos para el tratamiento del conducto alimentario. | |
| AR054382A1 (es) | Formulacion de compresion directa de un inhibidor de dipeptidil-peptidasa iv y una glitazona y proceso | |
| MY137768A (en) | Rapidly disintegrating methylcellulose tablets | |
| CO5390076A1 (es) | Composiciones farmaceuticas | |
| CO5160287A1 (es) | Formulacion de liberacion controlada de divalproex sodico | |
| EP0009688A3 (en) | Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases | |
| AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA | |
| ATE219061T1 (de) | Huperzin a analoge verbindungen | |
| RU2008107580A (ru) | Составы, содержащие базедоксифен ацетат | |
| ATE139438T1 (de) | Kaubare antacida | |
| BR0013106A (pt) | Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido. | |
| PE35498A1 (es) | Formulacion farmaceutica de famciclovir | |
| CO4410176A1 (es) | Formulaciones farmaceuticas de cefaclor | |
| ES2099021B1 (es) | Composicion farmaceutica que tiene actividad analgesica. | |
| AR021086A1 (es) | Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| MK | Expiration of term |